Guidelines of the Paul-Ehrlich-Society of Chemotherapy, the German Respiratory Diseases Society, the German Infectious Diseases Society and of the Competence Network CAPNETZ for the Management of Lower Respiratory Tract Infections and Community-acquired Pneumonia

Abstract

This document was downloaded for personal use only.Unauthorized distribution is strictly prohibited.macrolide resistance is of concern at least in patients with moderate to severe CAP. Microbial investigation !The amount of microbial investigation required depends on the severity of CAP.Recommendations for empiric initial antimicrobial treatment are based on local and national epidemiology. Clinical symptoms and findings in lower respiratory tract infection (LRTI) !The diagnosis of CAP cannot be firmly made on clinical grounds alone.Chest radiography remains the mainstay to differentiate LRTI and CAP.LRTIs include the following conditions which should be differentiated whenever possible: acute bronchitis, acute exacerbation of COPD, and influenza infection (Recommendation B). Management of LRTI! 1 500 mg orally 1 400 mg orally 5 -7 days 5 -7 days * In case of antibiotic pretreatment, change of the agent class is recommended.**In case of treatment failure or intolerance.